BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21707482)

  • 1. Ceramide transfer protein and cancer.
    Scheffer L; Raghavendra PR; Ma J; Acharya JK
    Anticancer Agents Med Chem; 2011 Nov; 11(9):904-10. PubMed ID: 21707482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer.
    Chung LH; Liu D; Liu XT; Qi Y
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast Svf1 binds ceramides and contributes to sphingolipid metabolism at the ER cis-Golgi interface.
    Limar S; Körner C; Martínez-Montañés F; Stancheva VG; Wolf VN; Walter S; Miller EA; Ejsing CS; Galassi VV; Fröhlich F
    J Cell Biol; 2023 May; 222(5):. PubMed ID: 36897280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular trafficking of ceramide by ceramide transfer protein.
    Hanada K
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(4):426-37. PubMed ID: 20431265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two sphingolipid transfer proteins, CERT and FAPP2: their roles in sphingolipid metabolism.
    Yamaji T; Kumagai K; Tomishige N; Hanada K
    IUBMB Life; 2008 Aug; 60(8):511-8. PubMed ID: 18459163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemistry and biology of 6-hydroxyceramide, the youngest member of the human sphingolipid family.
    Kováčik A; Roh J; Vávrová K
    Chembiochem; 2014 Jul; 15(11):1555-62. PubMed ID: 24990520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death.
    Mullen TD; Obeid LM
    Anticancer Agents Med Chem; 2012 May; 12(4):340-63. PubMed ID: 21707511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif.
    Sugiki T; Egawa D; Kumagai K; Kojima C; Fujiwara T; Takeuchi K; Shimada I; Hanada K; Takahashi H
    J Biol Chem; 2018 Jul; 293(28):11206-11217. PubMed ID: 29848549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipid targets in cancer therapy.
    Modrak DE; Gold DV; Goldenberg DM
    Mol Cancer Ther; 2006 Feb; 5(2):200-8. PubMed ID: 16505092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolism: ceramide transfer protein adds a new dimension.
    Hannun YA; Luberto C
    Curr Biol; 2004 Feb; 14(4):R163-5. PubMed ID: 15027471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide traffic in C6 glioma cells: evidence for CERT-dependent and independent transport from ER to the Golgi apparatus.
    Giussani P; Colleoni T; Brioschi L; Bassi R; Hanada K; Tettamanti G; Riboni L; Viani P
    Biochim Biophys Acta; 2008; 1781(1-2):40-51. PubMed ID: 18068681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism.
    Garcia V; Le Faouder P; Dupuy A; Levade T; Ballereau S; Génisson Y
    Chem Biodivers; 2015 Jul; 12(7):1115-25. PubMed ID: 26172331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity.
    Mu J; Lam SM; Shui G
    J Genet Genomics; 2024 Mar; 51(3):268-278. PubMed ID: 37364711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial sphingolipid uptake.
    Koch-Edelmann S; Banhart S; Saied EM; Rose L; Aeberhard L; Laue M; Doellinger J; Arenz C; Heuer D
    Cell Microbiol; 2017 Oct; 19(10):. PubMed ID: 28544656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Tocotrienol induces apoptosis in pancreatic cancer cells by upregulation of ceramide synthesis and modulation of sphingolipid transport.
    Palau VE; Chakraborty K; Wann D; Lightner J; Hilton K; Brannon M; Stone W; Krishnan K
    BMC Cancer; 2018 May; 18(1):564. PubMed ID: 29769046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide function in the brain: when a slight tilt is enough.
    Mencarelli C; Martinez-Martinez P
    Cell Mol Life Sci; 2013 Jan; 70(2):181-203. PubMed ID: 22729185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 protein pUL21 alters ceramide metabolism by activating the interorganelle transport protein CERT.
    Benedyk TH; Connor V; Caroe ER; Shamin M; Svergun DI; Deane JE; Jeffries CM; Crump CM; Graham SC
    J Biol Chem; 2022 Nov; 298(11):102589. PubMed ID: 36243114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.